Literature DB >> 21206339

Lipoprotein apheresis.

Gilbert R Thompson1.   

Abstract

PURPOSE OF REVIEW: Lipoprotein apheresis is being performed with increasing frequency, but better data collection and recording of clinical outcomes are needed. Setting up registries would facilitate this process. RECENT
FINDINGS: This review appraises recent articles that discuss the need for national registries and requirements for setting them up, the efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia and patients with coronary disease secondary to raised levels of lipoprotein (a), and its role in the management of acute pancreatitis secondary to severe hypertriglyceridaemia.
SUMMARY: Lipoprotein apheresis seems to be going through a growth spurt, presumably reflecting better implementation of treatment guidelines or a broadening of indications for its use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21206339     DOI: 10.1097/MOL.0b013e32833e13fd

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  15 in total

1.  The Italian Consensus Conferences on low density lipoprotein-cholesterol apheresis.

Authors:  Anja Vogt
Journal:  Blood Transfus       Date:  2016-07-07       Impact factor: 3.443

2.  Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels.

Authors:  Giulia Malaguarnera; Saverio Latteri; Vito Emanuele Catania; Michele Malaguarnera
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 3.  Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.

Authors:  Claudia Stefanutti; Gilbert R Thompson
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 4.  Lipoprotein (a): When to Measure and How to Treat?

Authors:  David Rhainds; Mathieu R Brodeur; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2021-07-08       Impact factor: 5.113

5.  Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.

Authors:  Klaus G Parhofer
Journal:  Core Evid       Date:  2012-05-31

6.  HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.

Authors:  Frank van Buuren; Sven Kreickmann; Dieter Horstkotte; Tanja Kottmann; Klaus Peter Mellwig
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

7.  Current view: indications for extracorporeal lipid apheresis treatment.

Authors:  Volker Schettler; C L Neumann; M Hulpke-Wette; G C Hagenah; E G Schulz; E Wieland
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

Review 8.  The genetics of familial hypercholesterolemia and emerging therapies.

Authors:  Anja Vogt
Journal:  Appl Clin Genet       Date:  2015-01-28

Review 9.  Familial hypercholesterolemia: A review.

Authors:  Mithun J Varghese
Journal:  Ann Pediatr Cardiol       Date:  2014-05

Review 10.  Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.

Authors:  Damon A Bell; Amanda J Hooper; Gerald F Watts; John R Burnett
Journal:  Vasc Health Risk Manag       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.